The US Pharma and Biotech Summit returned to New York on May 11, 2022. Industry leaders and FT journalists gathered to discuss regional and global trends in areas such as drug discovery, clinical development and market access. How is American investment in life sciences evolving? What are the prospects for healthcare reform? How can pharma companies become more patient-centric? Delegates joined us in-person and online to learn from experts, engage with leaders and network with peers.